Interaction Checker

Add peptides or compounds to check all pairwise interactions, cumulative organ load, and safety flags.

No conflicts detected. All interactions appear compatible based on available data.

Cumulative Organ Load

GI Tract
low
Pituitary
low
Blood Vessels
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (CJC/IPA Protocol, HGH). Monitor accordingly.
2x 2 compounds affect insulin sensitivity (CJC/IPA Protocol, HGH). Monitor fasting glucose and HbA1c.
%
CJC/IPA Protocol + HGH
Timing Required

GH secretagogues and exogenous GH compete via negative feedback. Exogenous GH suppresses natural GH pulses, reducing secretagogue efficacy. If combining, administer the secretagogue first and separate by 2+ hours.

Mechanism-based 51% confidence Administer secretagogue 2+ hours before exogenous GH Compare

Interaction data is compiled from research literature, pharmacological analysis, and community reports. Inferred interactions are based on known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.